June 21, 2006 article Open access Cyclophosphamide versus Placebo in Scleroderma Lung Disease New England Journal of Medicine DOI: 10.1056/nejmoa055120 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 5 stored of 1,688 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Fibrosis: cross-organ biology and pathways to development of innovative drugs 2025 Nature Reviews Drug Discovery review Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 97 citations Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment 2024 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 2 citations Interstitial Lung Disease 2023 Rheumatic Disease Clinics of North America article Medicine Systemic Sclerosis and Related Diseases Open access 11 citations Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis 2022 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access 23 citations Evolution of Systemic Sclerosis–Associated Interstitial Lung Disease One Year After Hematopoietic Stem Cell Transplantation or Cyclophosphamide 2020 Arthritis Care & Research article Medicine Systemic Sclerosis and Related Diseases Open access 21 citations 5 results References 0